Penote, Finn Alaister B.
HRN: 23-89-40 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
03/29/2025
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
03/29/2025
04/04/2025
IV
500
Q6
UTI
Waiting Final Action
Indication: Empiric Type of Infection: Urinary Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes